We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$355M
AUM Growth
-$58.3M
(-14%)
Cap. Flow
-$49.6M
Cap. Flow
% of AUM
-13.96%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$5.54M |
| 2 |
iShares MSCI Global Metals & Mining Producers ETF
PICK
|
+$4.8M |
| 3 |
Visa
V
|
+$4.5M |
| 4 |
Zoetis
ZTS
|
+$2.31M |
| 5 |
Wells Fargo
WFC
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$24.9M |
| 2 |
Ferrari
RACE
|
+$19.1M |
| 3 |
CNH
CNH Industrial
CNH
|
+$12.3M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$8.23M |
| 5 |
UBS Group
UBS
|
+$5.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.09% |
| 2 | Technology | 16.07% |
| 3 | Consumer Discretionary | 9.4% |
| 4 | Healthcare | 9.16% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Asana
ASAN
$2.21B
| $60K | 0.02% |
+1,501
| New | +$78.1K |
|
552
Patterson-UTI
PTEN
$4.59B
| $59.9K | 0.02% |
3,871
-295
| -7% | -$3.72K |
|
553
Pultegroup
PHM
$22.4B
| $59K | 0.02% |
1,408
+142
| +11% | +$7.05K |
|
554
Guardant Health
GH
$23.5B
| $58.6K | 0.02% |
884
-177
| -17% | -$12.1K |
|
555
Oracle
ORCL
$433B
| $58.2K | 0.02% |
+703
| New | +$56.9K |
|
556
Matsons
MATX
$7.05B
| $56K | 0.02% |
464
+2
| +0.4% | +$202 |
|
557
Cerence
CRNC
$355M
| $56K | 0.02% |
1,550
-229
| -13% | -$11.3K |
|
558
Hercules Capital
HTGC
$3.29B
| $55.9K | 0.02% |
3,094
-370
| -11% | -$6.5K |
|
559
Dave & Buster's
PLAY
$239M
| $55.2K | 0.02% |
1,124
+81
| +8% | +$3.24K |
|
|
PLXP
560
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $54.2K | 0.02% |
+13,407
| New | +$73.5K |
|
|
VMRK
561
Vivmark Residential
VMRK
$48.7B
| $53.9K | 0.02% |
599
| – | – |
|
562
TG Therapeutics
TGTX
$8.55B
| $53.7K | 0.02% |
+5,645
| New | +$65.3K |
|
563
ProShares Short 7-10 Year Treasury
TBX
$23.6M
| $51.7K | 0.01% |
2,000
| – | – |
|
564
Medtronic
MDT
$118B
| $51.5K | 0.01% |
464
| – | – |
|
565
Macy's
M
$5.7B
| $51.3K | 0.01% |
2,107
| – | – |
|
566
Emergent Biosolutions
EBS
$346M
| $51.1K | 0.01% |
1,245
-425
| -25% | -$18.7K |
|
|
CKPT
567
DELISTED
Checkpoint Therapeutics
CKPT
| $51.1K | 0.01% |
2,885
-241
| -8% | -$5.18K |
|
568
Dycom Industries
DY
$8.67B
| $51.1K | 0.01% |
536
-323
| -38% | -$29.6K |
|
569
Ferguson
FERG
$41.5B
| $50.9K | 0.01% |
374
-425
| -53% | -$65.6K |
|
570
Avery Dennison
AVY
$13.1B
| $49.9K | 0.01% |
+287
| New | +$53.4K |
|
|
BSL
571
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$169M
| $49.7K | 0.01% |
3,253
-4,300
| -57% | -$67.3K |
|
572
Simon Property Group
SPG
$65.7B
| $48.8K | 0.01% |
371
-200
| -35% | -$28.5K |
|
573
Corning
GLW
$124B
| $46.9K | 0.01% |
1,270
| – | – |
|
574
Mondelez International
MDLZ
$79.6B
| $46.8K | 0.01% |
746
| – | – |
|
|
ZNGA
575
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $46.8K | 0.01% |
+5,065
| New | +$44.5K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2022 Portfolio in Review
As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Exane Derivatives withdrew a net $49.6M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.
- Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
- Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
- Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
- Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
- Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
- Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
- Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.
Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.